BMS closes Redwood City cell therapy research site - Fierce Biotech



One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in the Bay Area concentrated on the tumor microenvironment.  | Bristol Myers Squibb is closing a 256,000-square-foot research facility in …